Monthly Investment Planning for Wegovy vs Mounjaro
What's the difference between Wegovy and Mounjaro monthly costs?
The monthly cost difference between Wegovy and Mounjaro reflects their distinct dosing schedules and mechanisms. Wegovy follows a 16-week escalation from £79.99 monthly (0.25mg starter dose) to £209.99 monthly (2.4mg maintenance), whilst Mounjaro has its own pricing structure. Both are prescription-only medicines requiring clinical assessment through our GPhC-registered service (#9012878). Wegovy's predictable monthly progression allows for clear financial planning: months 1-2 cost £79.99, months 3-4 cost £94.99, months 5-6 cost £99.99, months 7-8 cost £139.99, and month 9 onwards costs £209.99 for maintenance. This transparent pricing helps patients budget for long-term weight management commitment.
Understanding what's the difference between Wegovy and Mounjaro extends beyond monthly costs to include storage advantages and dosing flexibility. Wegovy pens maintain stability for 6 weeks at room temperature once removed from the fridge, compared to Mounjaro's 21-day limit—reducing travel concerns and storage anxiety. The monthly investment in either treatment represents commitment to clinically-proven weight management alongside diet and exercise modifications. Both medications are available through EverydayMeds with next-day cold-chain delivery, ensuring your monthly supply arrives safely and on schedule.
Wegovy pricing structure and discount codes
EverydayMeds provides transparent monthly pricing for Wegovy with automatic discount application at checkout. New customers use code FIRST40, whilst returning customers benefit from DOSE25 to reach our published prices. The 0.25mg starter dose costs £79.99 monthly, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and finally £209.99 for the 2.4mg maintenance dose. Annual maintenance cost totals approximately £2,520, making Wegovy a significant but manageable investment in long-term health outcomes. Bundle options provide convenience for patients preferring fewer monthly orders—our Intro Duo (0.25mg & 0.5mg) costs £169.99, covering the first two months of treatment.
What's the difference between Wegovy and Mounjaro becomes clear when examining value beyond monthly cost alone. Our Consistency bundles offer two months of the same dose: Consistency 2.4mg (×2) costs £419.99, providing maintenance supply security. The Ultimate Stability Trio delivers three months of 2.4mg maintenance doses for £649.99, ensuring uninterrupted treatment without monthly reordering. These pricing options reflect our commitment to making weight management accessible whilst maintaining the highest pharmaceutical standards through our MHRA-regulated supply chain.
Clinical evidence supporting Wegovy vs Mounjaro differences
Clinical trials demonstrate distinct mechanisms when evaluating what's the difference between Wegovy and Mounjaro. The STEP trials (Wilding et al., NEJM, 2021) showed patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo. Mounjaro's SURMOUNT trials revealed different outcomes due to its dual GIP and GLP-1 receptor activation. These trials used different methodologies, populations, and endpoints, making direct percentage comparisons inappropriate.
Both treatments require prescription-only access following clinical assessment to determine suitability. The monthly investment in either medication represents access to clinically-validated weight management support, not cosmetic enhancement. Long-term data suggests weight management requires ongoing commitment—STEP trial extensions showed patients regained approximately two-thirds of lost weight within one year of stopping treatment, emphasising that monthly costs represent sustained lifestyle intervention rather than short-term solutions.
How Wegovy works compared to Mounjaro mechanisms
Understanding what's the difference between Wegovy and Mounjaro begins with their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics naturally occurring fullness hormones, reducing appetite and promoting satiety after smaller meals. This mechanism may help reduce food cravings by working on brain appetite centres, supporting portion control and meal timing changes. The once-weekly injection schedule using FlexTouch pens provides consistent hormone level maintenance throughout the seven-day period. Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist, offering different receptor activation patterns that may produce varying responses between individuals.
Ordering process and monthly supply management
Both Wegovy and Mounjaro require identical ordering processes through our streamlined system. Patients complete a 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our prescribers review applications within 3 working days (or 24 hours with express service), ensuring appropriate clinical oversight for these prescription-only medicines. Once approved, next-day delivery via temperature-controlled cold-chain maintains medication stability from our pharmacy to your door. Monthly reordering reminders help maintain consistent treatment schedules, whilst our customer service team assists with dose escalation timing and delivery scheduling to prevent treatment interruptions.
Storage requirements and practical considerations
Storage differences highlight practical aspects of what's the difference between Wegovy and Mounjaro for monthly use. Wegovy pens require refrigeration at 2-8°C before first use but tolerate 6 weeks at room temperature below 30°C once removed, offering superior travel flexibility compared to Mounjaro's 21-day room temperature limit. Each pen contains four doses, requiring monthly replacement as you progress through dose escalation: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, continuing until reaching 2.4mg maintenance. The FlexTouch pen design simplifies weekly injections, with clear dose counters and safety features. Monthly storage planning becomes routine, with most patients keeping current pens at room temperature whilst storing backup supplies in the refrigerator.
Long-term monthly budgeting for Wegovy vs Mounjaro treatment
Financial planning for either treatment requires understanding the monthly cost progression and maintenance phase investment. Wegovy's escalation period totals £613.96 over four months (including all discount codes), followed by £209.99 monthly for maintenance—creating a predictable annual budget of approximately £3,133.84 for the first year. Subsequent years cost £2,519.88 annually at maintenance dose, representing significant but manageable healthcare investment. Both treatments qualify as medical expenses for tax purposes, and some patients explore private medical insurance coverage options.
What's the difference between Wegovy and Mounjaro extends to insurance acceptance and employer health scheme recognition. Many private healthcare policies now recognise prescription weight management medications as legitimate medical interventions rather than cosmetic treatments. Planning monthly costs alongside other healthcare expenses helps integrate treatment into household budgets, whilst our flexible bundle options reduce payment frequency for those preferring quarterly rather than monthly transactions. The long-term health benefits of sustained weight management often offset monthly medication costs through reduced comorbidity risks and improved quality of life.
Final considerations and getting started
Deciding what's the difference between Wegovy and Mounjaro ultimately depends on individual clinical factors, storage preferences, and monthly budget considerations. Both medications are available through EverydayMeds with identical clinical assessment standards and delivery options—your prescriber can help determine which treatment suits your specific circumstances. New customers benefit from code FIRST40, whilst returning customers use DOSE25 to access our competitive monthly pricing. Our complete service includes ongoing clinical support, delivery scheduling assistance, and access to weight management resources throughout your treatment journey. Start your clinical assessment today to begin planning your monthly weight management investment with transparent, professional pharmaceutical care.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
